Stockreport

Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer [Yahoo! Finance]

Tango Therapeutics, Inc.  (TNGX) 
PDF NEW HAVEN, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative tr [Read more]